These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11711289)

  • 61. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
    Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
    [No Abstract]   [Full Text] [Related]  

  • 63. Mycobacterium tuberculosis-Secreted Tyrosine Phosphatases as Targets Against Tuberculosis: Exploring Natural Sources in Searching for New Drugs.
    Mascarello A; Chiaradia-Delatorre LD; Mori M; Terenzi H; Botta B
    Curr Pharm Des; 2016; 22(12):1561-9. PubMed ID: 26759082
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antitubercular agents. Part 1: synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents.
    Kamal A; Hari Babu A; Venkata Ramana A; Sinha R; Yadav JS; Arora SK
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1923-6. PubMed ID: 15780634
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation.
    Medapi B; Suryadevara P; Renuka J; Sridevi JP; Yogeeswari P; Sriram D
    Eur J Med Chem; 2015 Oct; 103():1-16. PubMed ID: 26318054
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis and antimycobacterial activity of 4-[5-(substituted phenyl)-4, 5-dihydro-3-isoxazolyl]-2-methylphenols.
    Shaharyar M; Ali MA; Bakht MA; Murugan V
    J Enzyme Inhib Med Chem; 2008 Jun; 23(3):432-6. PubMed ID: 18569351
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages.
    Chen D; Ma S; He L; Yuan P; She Z; Lu Y
    Tuberculosis (Edinb); 2017 Mar; 103():37-43. PubMed ID: 28237032
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High-throughput screen for detecting antimycobacterial agents.
    Chung GA; Aktar Z; Jackson S; Duncan K
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2235-8. PubMed ID: 8619574
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis of disaccharides related to the mycobacterial arabinogalactan.
    Pathak AK; Pathak V; Khare NK; Maddry JA; Reynolds RC
    Carbohydr Lett; 2001; 4(2):117-22. PubMed ID: 11506156
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol.
    Zhang L; Zhao Y; Gao Y; Wu L; Gao R; Zhang Q; Wang Y; Wu C; Wu F; Gurcha SS; Veerapen N; Batt SM; Zhao W; Qin L; Yang X; Wang M; Zhu Y; Zhang B; Bi L; Zhang X; Yang H; Guddat LW; Xu W; Wang Q; Li J; Besra GS; Rao Z
    Science; 2020 Jun; 368(6496):1211-1219. PubMed ID: 32327601
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification and synthesis of novel inhibitors of mycobacterium ATP synthase.
    Surase YB; Samby K; Amale SR; Sood R; Purnapatre KP; Pareek PK; Das B; Nanda K; Kumar S; Verma AK
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3454-3459. PubMed ID: 28587823
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fragment Discovery for the Design of Nitrogen Heterocycles as Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors.
    Shelke RU; Degani MS; Raju A; Ray MK; Rajan MG
    Arch Pharm (Weinheim); 2016 Aug; 349(8):602-13. PubMed ID: 27320965
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
    Segura-Cabrera A; Rodríguez-Pérez MA
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
    Portell-Buj E; Vergara A; Alejo I; López-Gavín A; Monté MR; San Nicolás L; González-Martín J; Tudó G
    J Med Microbiol; 2019 Feb; 68(2):211-215. PubMed ID: 30570475
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Drug repurposing against arabinosyl transferase (EmbC) of Mycobacterium tuberculosis: Essential dynamics and free energy minima based binding mechanics analysis.
    Singh A; Somvanshi P; Grover A
    Gene; 2019 Apr; 693():114-126. PubMed ID: 30716439
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis.
    Giacobbo BC; Pissinate K; Rodrigues-Junior V; Villela AD; Grams ES; Abbadi BL; Subtil FT; Sperotto N; Trindade RV; Back DF; Campos MM; Basso LA; Machado P; Santos DS
    Eur J Med Chem; 2017 Jan; 126():491-501. PubMed ID: 27914363
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and evaluation of 5-substituted 2'-deoxyuridine monophosphate analogues as inhibitors of flavin-dependent thymidylate synthase in Mycobacterium tuberculosis.
    Kögler M; Vanderhoydonck B; De Jonghe S; Rozenski J; Van Belle K; Herman J; Louat T; Parchina A; Sibley C; Lescrinier E; Herdewijn P
    J Med Chem; 2011 Jul; 54(13):4847-62. PubMed ID: 21657202
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
    Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target.
    Manina G; Pasca MR; Buroni S; De Rossi E; Riccardi G
    Curr Med Chem; 2010; 17(27):3099-108. PubMed ID: 20629622
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
    Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
    Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.